Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „significantly“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Krka · 4.5 · 7 A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicis
Eintrag öffnenClopidogrel TAD · 4.5 · 7 A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicis
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.5 · A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicista
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicista
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicista
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicista
Eintrag öffnenClopidogrel ratiopharm · 4.5 · A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicista
Eintrag öffnenCombivir · 4.5 · Lamivudine and zidovudine are not significantly metabolised by cytochrome P450 enzymes (such as CYP 3A4, CYP 2
Eintrag öffnenCresemba · 4.5 · Isavuconazole drug concentrations may significantly decrease.
Eintrag öffnenCresemba · 4.5 · Isavuconazole drug concentrations may significantly decrease.
Eintrag öffnenCymbalta · 4.5 · 7 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily).
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · 89 dabigatran etexilate twice daily had a significantly higher risk for major GI bleeds compared with warfarin
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · Subjects randomised to dabigatran etexilate 110 mg twice daily or 150 mg twice daily had a significantly lower
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · Subjects randomised to dabigatran etexilate 110 mg twice daily or 150 mg twice daily had a significantly lower
Eintrag öffnenDaptomycin Hospira · 4.5 · 8 products alter the pharmacokinetics of daptomycin. The pharmacokinetics of daptomycin were not significantly
Eintrag öffnenDeferasirox Accord · 4.5 · Cholestyramine significantly reduced the deferasirox exposure in a mechanistic study to determine the degree o
Eintrag öffnenDeferasirox Mylan · 4.5 · Cholestyramine significantly reduced the deferasirox exposure in a mechanistic study to determine the degree o
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnen